Nereus Pharmaceuticals Receives $20,000,000 New Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1cb2eb05-5233-420d-9dff-69a124cf55ff&Preview=1 -
Date
6/23/2010 -
Company Name
Nereus Pharmaceuticals -
Mailing Address
10480 Wateridge Circle San Diego, CA 92121 -
Company Description
Nereus Pharmaceuticals is an innovative drug discovery and development company pursuing untapped sources of chemical diversity. -
Website
http://www.nereuspharm.com -
Transaction Type
Venture Equity -
Transaction Amount
$20,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Nereus has made significant clinical progress with its anti-cancer agents, plinabulin and marizomib, two highly differentiated product candidates that are progressing nicely through mid-stage clinical trials towards pivotal studies. -
M&A Terms
-
Venture Investor
HBM Bioventures -
Venture Investor
Advent International -
Venture Investor
Forward Ventures -
Venture Investor
Alta Partners -
Venture Investor
Gimv -
Venture Investor
Roche Venture Fund -
Venture Investor
Astellas Venture Management LLC
